The Five Most Important Takeaways From Lung Cancer Awareness Month
“Since November is lung cancer awareness month, it behooves us to reflect on some of the most important aspects of this deadly cancer that has taken the lives of so many. Below are five important lessons we can all learn about lung cancer that may not be so obvious.”
Lung Cancer Screening Can Catch Tumors When They’re Curable, New Research Finds
“For the past six years, Elyssa Barbaro has gotten screened for lung cancer. The 71-year-old New Yorker smoked for about 50 years, but she doubts she would have gotten an annual preventative CT scan if her pulmonologist hadn’t told her she should. Even though the procedure takes just 15 minutes, it saved her life—more than once. During her CT scans in 2019 and 2020, cancer was discovered in Barbaro’s lungs.”
Why Are More Millennial Women Getting Lung Cancer?
“New studies show more young women between the ages of 30 to 49 are being diagnosed with lung cancer.”
Updates Results Support Repotrectinib in ROS1+ NSCLC
“Updated findings from the TRIDENT-1 suggest that repotrectinib could represent a potential new treatment option for patients with ROS1- positive advanced non–small cell lung cancer, according to Byoung Chul Cho, MD, PhD.”
Fight against lung cancer is changing thanks to robotics
(NewsNation) — “More than 600,000 Americans are expected to die of cancer in 2022 — an outcome often the result of a delayed diagnosis. That’s particularly true for lung cancer, accounting for one in four cancer deaths.”
Representatives Castor and Higgins Introduce Legislation to Increase Access to Lung Cancer Screening
“Legislation Will Remove Barriers to Lung Cancer Screenings Across the United States”
Lung Cancer Screening May Increase Long-Term Survival Rate
“Diagnosing early-stage lung cancer using low-dose computed tomography (CT) screenings may improve patients’ long-term survival rate, according to long-term findings from the International Early Lung Cancer Action Program presented at the Radiological Society of North America (RSNA) 2022 Annual Meeting.”
Domvanalimab Combination Shows Clinically Meaningful Progression-Free Survival in Lung Cancer
“Data from the fourth interim analysis of the ARC-7 trial shows that a combination of Fc-silent anti-TIGIT and anti-PD-1 molecules are effective for objective response rates in certain lung cancers.”
Racial Disparities in Lung Cancer Start With Research
“During a routine visit to the Good Samaritan Clinic in Morganton, North Carolina, in 2018, Herbert Buff casually mentioned that he sometimes had trouble breathing.”
How a Biomarker Test Saved This Lung Cancer Survivor’s Life
“Brittany Hawkins was diagnosed with stage IV lung cancer and given 3-6 months to live. Then a biomarker test led to targeted treatment that changed everything.”
Simultaneous radiation and immunotherapy are beneficial for a subset of lung cancer patients
“In many cancer types, cancer cells try to survive by escaping attacks from the immune system. These cancer cells hijack mechanisms called immune checkpoints to trick the immune system into thinking they are healthy cells. Recent advances in cancer treatment have focused on developing immune checkpoint blockers, which have revolutionized treatment approaches for many cancer patients, including those with metastatic non-small cell lung cancer (mNSCLC).”
